Ropes & Gray acted as legal advisor to TransMedics, and Cooley acted as legal advisor to Bridge to Life. TransMedics Group, Inc. (Nasdaq: TMDX) announced that is...
You must be a Standard 1 Year member to access this content.
Cooley advised Kriya on the fundraising. Kriya Therapeutics, Inc. announced the addition of over $150 million in capital committed as part of its Series C Financing,...
You must be a Standard 1 Year member to access this content.
Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
You must be a Standard 1 Year member to access this content.
Cooley advised Kriya Therapeutics on the deal. Kriya Therapeutics, a fully integrated gene therapy company pioneering novel technologies and therapeutics, announced its $270 Million Series C financing...
You must be a Standard 1 Year member to access this content.
Cooley advised Lacework on the deal. Lacework, a data-driven security platform for the cloud, announced its $1.3 billion Series D financing round, which brings its valuation to...
You must be a Standard 1 Year member to access this content.
Latham & Watkins Advises the Underwriters in the offering while Cooley LLP represented Lyell Immunopharma. Lyell Immunopharma, Inc. (Lyell), (Nasdaq: LYEL), a T cell reprogramming company...
You must be a Standard 1 Year member to access this content.
NautaDutilh and Weil, Gotshal & Manges advised Blackstone Growth on the deal and De Brauw has advised Mollie. Freshfields Bruckhaus Deringer advised EQT Growth. Kennedy Van...
You must be a Standard 1 Year member to access this content.
